When Medtronic’s Infuse Bone Graft was first approved by the FDA in 2002, the innovation was hailed as a major breakthrough that could stimulate the formation of new bone mass when used in spinal fusion procedures. Medtronic’s own website waxed poetic about the breakthrough, comparing it to The Anatomy Lecture... Read more »

On April 14, plaintiff Eileen Laferrera filed a product liability complaint against Medtronic, alleging off-label use of the company’s Infuse bone graft during her surgery was the direct and proximate cause of her injuries. Her Infuse bone graft lawsuit was brought in the U.S. District Court, District of New Jersey,... Read more »

The majority of medical product liability cases are filed in federal district courts. Accordingly, the Federal Rules of Civil Procedure apply to each case from the initial complaint to the final appeal. These rules were enacted by Congress and are perpetually being amended and updated, requiring the savvy litigator to... Read more »

A new FDA bone graft warning has been issued, advising doctors to avoid off-label use of certain bone graft substitutes in patients with bone disorders, who are younger than 18 years old ─ this includes Medtronic’s Infuse bone graft. The FDA noted that these bone graft substitutes could cause serious... Read more »

On August 4th, the judge presiding over a Medtronic Infuse Bone Graft lawsuit struck a blow to the manufacturer in a product liability lawsuit pending in St. Louis. Judge Carol E. Jackson, presiding over the personal injury lawsuit involving the Infuse Bone Graft device in the U.S. District Court for... Read more »

Minnesota-based medical device company Medtronic has agreed to pay $9.9 million to the federal government in order to settle allegations arising under the False Claims Act – a federal statute designed to incentivize integrity and undermine the efforts of those fraudulently submitting invoices for payment under government contracts. The False... Read more »

A Medtronic INFUSE bone graft settlement was recently announced, with the medical technology company agreeing to pay $22 million to settle approximately 1,000 legal claims over the controversial spine surgery product. Medtronic is also setting an additional $140 million aside to fund an even larger number of expected claims. The... Read more »